SCARICA IL MANUALE JBI PER LA SINTESI DELLE EVIDENZE “FREE” !

JBIMANUAL FOR EVIDENCE SYNTHESIS April 2021 JBI Manual for Evidence Synthesis Welcome to the JBI Manual for Evidence Synthesis JBI is an international evidence-based healthcare research organisation that works with 70+ Universities and Hospitals (known as the JBI Collaboration) around the world. The organisation focuses on improving health outcomes globally by producing and disseminating research…

UN NUOVO INIBITORE PER LA TERAPIA DELLA NASH DA GASTROENTEROLOGY: UN TRIAL

TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial Rohit Loomba et al. Background & Aims Increased de novo lipogenesis creates excess intrahepatic fat and lipotoxins, propagating liver damage in nonalcoholic steatohepatitis. TVB-2640, a fatty acid synthase inhibitor, was designed to reduce excess liver fat and directly inhibit…

DA FANS AD OPIOIDI : FATTORI DI RISCHIO PER IL MAL DI SCHIENA. UNO STUDIO DI REAL-WORLD EVIDENCE DALLA CAMPANIA

Predictors of Opioid Prescribing for Non-Malignant Low Back Pain in an Italian Primary Care Setting Simona Cammarota et al. This study explores which patient characteristics could affect the likelihood of starting low back pain (LBP) treatment with opioid analgesics vs. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in an Italian primary care setting. Through the computerized medical records…

PERCORSO DIAGNOSTICO E GESTIONALE DEL PAZIENTE CON NASH: UN “CLINICAL CARE PATHWAY” DA AGA

Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease Fasiha Kanwal et al. Find AGA’s NASH Clinical Care Pathway App for iOS and Android mobile devices at nash.gastro.org. Scan this QR code to be taken directly to the website.Nonalcoholic fatty liver disease (NAFLD) is becoming increasingly common, currently affecting…

TRE GRAVI ERRORI O MITI SUL COVID -19. UN DOC “FREE” DAL REAL CENTRE DOPO UN ANNO DI EPIDEMIA

REAL Centre. One year on Three myths about COVID-19 that the data proved wrong Data analysis (PDF version) • 23 March 2021 Holly Krelle, Charles Tallack About this article The charts in this analysis highlight three ‘myths’ that were prevalent at the very start of the pandemic. We use a common measure ‘years of life…

MORTALITA’ DA COVID-19 vs INFLUENZA: 206 vs 1.8 per 100 000 da BMJ ( GRAN BRETAGNA ED USA).

Covid and flu: what do the numbers tell us about morbidity and deaths? Much confusion has been seen in the UK media about the effects on mortality of flu and covid-19. Gareth Iacobucci Are there more deaths from flu than from covid? Data from the Office for National Statistics show that in England and Wales…